Skip to main content
. 2013 Oct 21;76(5):810–815. doi: 10.1111/bcp.12090

Table 2.

Case–crossover analysis: effect of antidepressants on the risk of crash

Antidepressants Case period (n) Control period 1 (n) OR (95% CI) Control period 2 (n) OR (95% CI) Control period 3 (n) OR (95% CI) Control period 4 (n) OR (95% CI) Control period 5 (n) OR (95% CI) Control period 6 (n) OR (95% CI) Control period 7 (n) OR (95% CI) Control period 8 (n) OR (95% CI)
All* 2919 2933 0.98 (0.89, 1.09) 2858 1.09 (0.98, 1.20) 2847 1.09 90.99, 1.21) 2765 1.19 (1.08, 1.30) 2675 1.29 (1.18, 1.42) 2661 1.29 (1.18, 1.41) 2612 1.36 (1.24, 1.48) 2554 1.42 (1.30, 1.55)
Tricyclics 1745 1745 1.00 (0.87, 1.14) 1725 1.05 (0.92, 1.20) 1722 1.05 (0.92, 1.20) 1694 1.11 (0.98, 1.25) 1745 1.00 (0.88, 1.15) 1715 1.08 (0.94, 1.23) 1723 1.05 (0.92, 1.20) 1683 1.13 (1.00, 1.28)
SSRIs 788 782 1.03 (0.85, 1.25) 739 1.25 (1.04, 1.51) 750 1.17 (0.98, 1.39) 708 1.35 (1.14, 1.60) 778 1.05 (0.86, 1.27) 743 1.22 (1.01, 1.47) 725 1.28 (1.07, 1.53) 715 1.31 (1.10, 1.55)
Others 214 225 0.85 (0.60, 1.19) 222 0.89 (0.63. 1.25) 204 1.16 (0.83, 1.63) 199 1.19 (0.88, 1.62) 222 0.88 (0.62, 1.25) 220 0.92 (0.67, 1.27) 217 0.96 (0.69, 1.34) 193 1.30 (0.95, 1.79)
*

Exposed to at least one antidepressant.

Exposed to an antidepressant of this class only.